Abstract:Objective: Paternal sperm mosaicism has few consequences for fathers for mutations being restricted to sperm. However, it could potentially underlie severe sporadic disease in their offspring. Here, we present a live birth of a female infant from a father with low-level sperm DNA mosaicism achieved via preimplantation genetic testing for monogenic disorders (PGT-M).Methods: A couple with the father carrying sperm DNA mosaicism received standard in vitro fertilization treatment, with intracytoplasmic sperm injection, embryo biopsy, polymerase chain reaction, and DNA analysis. Only one unaffected embryo was transferred to the uterine cavity. Amniocentesis was performed at the 16th week of gestation by copy-number variation-sequencing, karyotyping, and Sanger sequencing.Results: Eight surviving embryos were biopsied during the blastocyst stage. Karyomapping and Sanger sequencing were applied to detect the euploidy and paternal mutation. After performing PGT-M, followed by successful pregnancy, the prenatal genetic diagnoses revealed that the fetus was unaffected, and one healthy girl was born.Conclusion: This is the first reported live birth with unaffected children achieved via PGT for a low-level germline mosaicism father. It not only opens the possibility of preventing the recurrent monogenic disease of children among gonadal mosaicism families but also alerts clinicians to consider gonadal mosaicism as the source of DMNs.

[Focus on the development of preimplantation genetic testing in the field of birth defects and rare diseases prevention and control]

Research Progress and Challenges of Preimplantation Genetic Testing for Polygenic Diseases.

Application of the High-throughput Technologies in Preimplantation Genetic Diagnosis

"5G + Blockchain"--enabled preimplantation genetic testing for precise prevention and control of rare disease

Development of Preimplantation Genetic Testing for Monogenic Diseases in China

Application and Challenge of Preimplantation Genetic Testing in Reproductive Medicine

A Novel Preimplantation Genetic Testing Strategy for a Subtelomeric Genetic Disorder: A Case Study

Clinical application and reflection of molecular biology technology in the tertiary prevention of birth defects

Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers.

Current Status and New Progress of the Preimplantation Genetic Testing

Chinese experts' consensus guideline on preimplantation genetic testing of monogenic disorders

Living Birth Following Preimplantation Genetic Testing for Monogenic Disorders to Prevent Low-Level Germline Mosaicism Related Nicolaides–Baraitser Syndrome

Advances in Preimplantation Genetic Diagnosis/screening

Current Status and Recent Advances in Preimplantation Genetic Testing for Structural Rearrangements

[Advance in the Methods of Preimplantation Genetic Diagnosis for Single Gene Diseases].

[Advances on Prenatal Diagnosis of Birth Defects Associated with Genetic Disorders].

Development of preimplantation genetic testing for monogenic reference materials using next-generation sequencing

Preimplantation genetic testing in the current era, a review

Noninvasive preimplantation genetic testing in assisted reproductive technology: current state and future perspectives

Preimplantation genetic testing for monogenic disorders (PGT-M) offers an alternative strategy to prevent children from being born with hereditary neurological diseases or metabolic diseases dominated by nervous system phenotypes: a retrospective study

[Retrospect and prospect of the genetic research on birth defects <br/>in China].